HUMAN GENOME SCIENCES INC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | FY09 | |
|---|---|---|---|
| Revenue | $26.6M | $46.5M | $275.7M |
| Operating income | −$116.0M | −$37.8M | $6.2M |
| Net income | −$131.0M | −$47.9M | $5.7M |
| Total assets | $1.41B | $1.32B | — |
| Total liabilities | $951.2M | $729.3M | — |
| Equity | $456.4M | $585.8M | $755.4M |
| EPS (diluted) | — | — | — |
| Shares out. | 198.8M | 189.0M | 155.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- −436.5%
- Net margin
- −493.0%
- Return on equity
- −28.7%
- Return on assets
- −9.3%
- Return on capital (ROCE)
- −10.7%
- Liabilities / assets
- 67.6%
- Debt / equity
- 2.08×
- Book value / share
- $2.30
- Revenue growth (YoY)
- −42.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Altman Z″ (distress)
- -5.02distress
- Accruals / assets
- 19.0%high accruals
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 warning● 0 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Amended charter or bylawsAug 8, 2012
- Entered a material agreement · Debt acceleration / triggering event · Change in control · Director / officer changeAug 1, 2012
- Entered a material agreement · Modified shareholder rights · Other material eventJul 16, 2012
- Entered a material agreement · Modified shareholder rights · Regulation FD disclosureMay 17, 2012
- Shareholder voteMay 16, 2012
- Results of operationsApr 24, 2012
- Other material eventApr 19, 2012
- Results of operationsFeb 27, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.